These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27521268)

  • 1. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity.
    Ban T; Sato GR; Nishiyama A; Akiyama A; Takasuna M; Umehara M; Suzuki S; Ichino M; Matsunaga S; Kimura A; Kimura Y; Yanai H; Miyashita S; Kuromitsu J; Tsukahara K; Yoshimatsu K; Endo I; Yamamoto T; Hirano H; Ryo A; Taniguchi T; Tamura T
    Immunity; 2016 Aug; 45(2):319-32. PubMed ID: 27521268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus.
    Ban T; Sato GR; Tamura T
    Int Immunol; 2018 Oct; 30(11):529-536. PubMed ID: 29860420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice.
    Hua Z; Gross AJ; Lamagna C; Ramos-Hernández N; Scapini P; Ji M; Shao H; Lowell CA; Hou B; DeFranco AL
    J Immunol; 2014 Feb; 192(3):875-85. PubMed ID: 24379120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation.
    Lamagna C; Scapini P; van Ziffle JA; DeFranco AL; Lowell CA
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3311-20. PubMed ID: 23940344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.
    Ban T; Kikuchi M; Sato GR; Manabe A; Tagata N; Harita K; Nishiyama A; Nishimura K; Yoshimi R; Kirino Y; Yanai H; Matsumoto Y; Suzuki S; Hihara H; Ito M; Tsukahara K; Yoshimatsu K; Yamamoto T; Taniguchi T; Nakajima H; Ito S; Tamura T
    Nat Commun; 2021 Jul; 12(1):4379. PubMed ID: 34282144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyD88-dependent autoimmune disease in Lyn-deficient mice.
    Silver KL; Crockford TL; Bouriez-Jones T; Milling S; Lambe T; Cornall RJ
    Eur J Immunol; 2007 Oct; 37(10):2734-43. PubMed ID: 17853409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src-family-tyrosine kinase Lyn is critical for TLR2-mediated NF-κB activation through the PI 3-kinase signaling pathway.
    Toubiana J; Rossi AL; Belaidouni N; Grimaldi D; Pene F; Chafey P; Comba B; Camoin L; Bismuth G; Claessens YE; Mira JP; Chiche JD
    Innate Immun; 2015 Oct; 21(7):685-97. PubMed ID: 26055819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcγR-TLR Cross-Talk Enhances TNF Production by Human Monocyte-Derived DCs via IRF5-Dependent Gene Transcription and Glycolytic Reprogramming.
    Hoepel W; Newling M; Vogelpoel LTC; Sritharan L; Hansen IS; Kapsenberg ML; Baeten DLP; Everts B; den Dunnen J
    Front Immunol; 2019; 10():739. PubMed ID: 31024565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.
    Savitsky DA; Yanai H; Tamura T; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10154-9. PubMed ID: 20479222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
    Cushing L; Winkler A; Jelinsky SA; Lee K; Korver W; Hawtin R; Rao VR; Fleming M; Lin LL
    J Biol Chem; 2017 Nov; 292(45):18689-18698. PubMed ID: 28924041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD9 mediates dendritic cell-induced development of Lyn deficiency-associated autoimmune and inflammatory diseases.
    Ma J; Abram CL; Hu Y; Lowell CA
    Sci Signal; 2019 Oct; 12(602):. PubMed ID: 31594855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus.
    L'Estrange-Stranieri E; Gottschalk TA; Wright MD; Hibbs ML
    Front Immunol; 2024; 15():1395427. PubMed ID: 39007135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.
    Brodie EJ; Infantino S; Low MSY; Tarlinton DM
    Front Immunol; 2018; 9():401. PubMed ID: 29545808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
    Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
    Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.
    Teichmann LL; Schenten D; Medzhitov R; Kashgarian M; Shlomchik MJ
    Immunity; 2013 Mar; 38(3):528-40. PubMed ID: 23499488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyn kinase controls TLR4-dependent IKK and MAPK activation modulating the activity of TRAF-6/TAK-1 protein complex in mast cells.
    Avila M; Martinez-Juarez A; Ibarra-Sanchez A; Gonzalez-Espinosa C
    Innate Immun; 2012 Aug; 18(4):648-60. PubMed ID: 22302035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.
    Cham CM; Ko K; Niewold TB
    Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage-Specific Functionality of an Interferon Regulatory Factor 5 Lupus Risk Haplotype: Lack of B Cell Intrinsic Effects.
    Calise J; Marquez Renteria S; Gregersen PK; Diamond B
    Front Immunol; 2018; 9():996. PubMed ID: 29867973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.